KIORA PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense
KIORA PHARMACEUTICALS, INC. (KPRX) reported Share-based Payment Arrangement, Expense of $211.74 thousand for the 1-month period ending 2015-09-01, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2016-03-30
- 2015-09-01: Share-based Payment Arrangement, Expense 1 month $211.74K.
- 2015-05-01: Share-based Payment Arrangement, Expense 1 month $42.43K.
| Period end | Share-based Payment Arrangement, Expense 1 month |
|---|---|
| 2015-09-01 | $211.74K 10-K · filed 2016-03-30 |
| 2015-05-01 | $42.43K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |